Works matching AU Narita, Shintaro

Results: 152
    1

    Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 3, p. 204, doi. 10.1007/s10147-011-0275-6
    By:
    • Narita, Shintaro;
    • Tsuchiya, Norihiko;
    • Yuasa, Takeshi;
    • Maita, Shinya;
    • Obara, Takashi;
    • Numakura, Kazuyuki;
    • Tsuruta, Hiroshi;
    • Saito, Mitsuru;
    • Inoue, Takamitsu;
    • Horikawa, Yohei;
    • Satoh, Shigeru;
    • Habuchi, Tomonori
    Publication type:
    Article
    2
    3
    4
    5
    6

    Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.

    Published in:
    JNCI Cancer Spectrum, 2022, v. 6, n. 1, p. 1, doi. 10.1093/jncics/pkac001
    By:
    • Akamatsu, Shusuke;
    • Terada, Naoki;
    • Takata, Ryo;
    • Kinoshita, Hidefumi;
    • Shimatani, Kimihiro;
    • Momozawa, Yukihide;
    • Yamamoto, Michio;
    • Tada, Harue;
    • Kawamorita, Naoki;
    • Narita, Shintaro;
    • Kato, Takuma;
    • Nitta, Masahiro;
    • Kandori, Shuya;
    • Koike, Yusuke;
    • Inazawa, Johji;
    • Kimura, Takahiro;
    • Kimura, Hiroko;
    • Kojima, Takahiro;
    • Terachi, Toshiro;
    • Sugimoto, Mikio
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 10, p. 984, doi. 10.1093/jjco/hyad088
    By:
    • Tohi, Yoichiro;
    • Ishikawa, Ryou;
    • Kato, Takuma;
    • Miyakawa, Jimpei;
    • Matsumoto, Ryuji;
    • Mori, Keiichiro;
    • Mitsuzuka, Koji;
    • Inokuchi, Junichi;
    • Matsumura, Masafumi;
    • Shiga, Kenichiro;
    • Naito, Hirohito;
    • Kohjimoto, Yasuo;
    • Kawamura, Norihiko;
    • Inoue, Masaharu;
    • Akamatsu, Shusuke;
    • Terada, Naoki;
    • Miyazawa, Yoshiyuki;
    • Narita, Shintaro;
    • Haba, Reiji;
    • Sugimoto, Mikio
    Publication type:
    Article
    14

    Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 12, p. 1441, doi. 10.1093/jjco/hyac141
    By:
    • Sekine, Yuya;
    • Iwasaki, Yusuke;
    • Hakozaki, Nozomi;
    • Endo, Mikiko;
    • Kamatani, Yoichiro;
    • Matsuda, Koichi;
    • Murakami, Yoshinori;
    • Sano, Takeshi;
    • Akamatsu, Shusuke;
    • Kobayashi, Takashi;
    • Nakagawa, Hidewaki;
    • Numakura, Kazuyuki;
    • Narita, Shintaro;
    • Habuchi, Tomonori;
    • Momozawa, Yukihide
    Publication type:
    Article
    15
    16

    Management of prostate cancer in older patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 6, p. 513, doi. 10.1093/jjco/hyac016
    By:
    • Narita, Shintaro;
    • Hatakeyama, Shingo;
    • Sakamoto, Shinichi;
    • Kato, Takuma;
    • Inokuchi, Juichi;
    • Matsui, Yoshiyuki;
    • Kitamura, Hiroshi;
    • Nishiyama, Hiroyuki;
    • Habuchi, Tomonori
    Publication type:
    Article
    17

    Management of bladder cancer in older patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 3, p. 203, doi. 10.1093/jjco/hyab187
    By:
    • Hatakeyama, Shingo;
    • Narita, Shintaro;
    • Okita, Kazutaka;
    • Narita, Takuma;
    • Iwamura, Hiromichi;
    • Fujita, Naoki;
    • Inokuchi, Junichi;
    • Matsui, Yoshiyuki;
    • Kitamura, Hiroshi;
    • Ohyama, Chikara
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25

    Altered miRNA expression in high-fat diet-induced prostate cancer progression.

    Published in:
    Carcinogenesis, 2016, v. 37, n. 12, p. 1229, doi. 10.1093/carcin/bgw108
    By:
    • Taketoshi Nara;
    • Shintaro Narita;
    • Huang Mingguo;
    • Toshiaki Yoshioka;
    • Atsushi Koizumi;
    • Kazuyuki Numakura;
    • Hiroshi Tsuruta;
    • Atsushi Maeno;
    • Mitsuru Saito;
    • Takamitsu Inoue;
    • Norihiko Tsuchiya;
    • Shigeru Satoh;
    • Tomonori Habuchi
    Publication type:
    Article
    26
    27
    28

    Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.

    Published in:
    BJU International, 2022, v. 130, n. 2, p. 226, doi. 10.1111/bju.15510
    By:
    • Kobayashi, Mizuki;
    • Narita, Shintaro;
    • Matsui, Yoshiyuki;
    • Kanda, Souhei;
    • Hidaka, Yu;
    • Abe, Hiroyasu;
    • Tsuzuki, Toyonori;
    • Ito, Katsuhiro;
    • Kojima, Takahiro;
    • Kato, Minoru;
    • Hatakeyama, Shingo;
    • Matsushita, Yuto;
    • Naito, Sei;
    • Shiga, Masanobu;
    • Miyake, Makito;
    • Muro, Yusuke;
    • Nakanishi, Shotaro;
    • Kato, Yoichiro;
    • Shibuya, Tadamasa;
    • Hayashi, Tetsutaro
    Publication type:
    Article
    29
    30
    31

    Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.

    Published in:
    Human Molecular Genetics, 2022, v. 31, n. 12, p. 1962, doi. 10.1093/hmg/ddab345
    By:
    • Sekine, Yuya;
    • Iwasaki, Yusuke;
    • Aoi, Tomomi;
    • Endo, Mikiko;
    • Hirata, Makoto;
    • Kamatani, Yoichiro;
    • Matsuda, Koichi;
    • Sugano, Kokichi;
    • Yoshida, Teruhiko;
    • Murakami, Yoshinori;
    • Fukui, Tomohiro;
    • Akamatsu, Shusuke;
    • Ogawa, Osamu;
    • Nakagawa, Hidewaki;
    • Numakura, Kazuyuki;
    • Narita, Shintaro;
    • Habuchi, Tomonori;
    • Momozawa, Yukihide
    Publication type:
    Article
    32
    33
    34

    Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.

    Published in:
    Cancer Science, 2022, v. 113, n. 12, p. 4059, doi. 10.1111/cas.15488
    By:
    • Takahashi, Shuhei;
    • Narita, Shintaro;
    • Fujiyama, Nobuhiro;
    • Hatakeyama, Shingo;
    • Kobayashi, Takashi;
    • Kato, Renpei;
    • Naito, Sei;
    • Sakatani, Toru;
    • Kashima, Soki;
    • Koizumi, Atsushi;
    • Yamamoto, Ryohei;
    • Nara, Taketoshi;
    • Kanda, Souhei;
    • Numakura, Kazuyuki;
    • Saito, Mitsuru;
    • Obara, Wataru;
    • Tsuchiya, Norihiko;
    • Ohyama, Chikara;
    • Ogawa, Osamu;
    • Habuchi, Tomonori
    Publication type:
    Article
    35

    Machine learning diagnosis by immunoglobulin N‐glycan signatures for precision diagnosis of urological diseases.

    Published in:
    Cancer Science, 2022, v. 113, n. 7, p. 2434, doi. 10.1111/cas.15395
    By:
    • Iwamura, Hiromichi;
    • Mizuno, Kei;
    • Akamatsu, Shusuke;
    • Hatakeyama, Shingo;
    • Tobisawa, Yuki;
    • Narita, Shintaro;
    • Narita, Takuma;
    • Yamashita, Shinichi;
    • Kawamura, Sadafumi;
    • Sakurai, Toshihiko;
    • Fujita, Naoki;
    • Kodama, Hirotake;
    • Noro, Daisuke;
    • Kakizaki, Ikuko;
    • Nakaji, Shigeyuki;
    • Itoh, Ken;
    • Tsuchiya, Norihiko;
    • Ito, Akihiro;
    • Habuchi, Tomonori;
    • Ohyama, Chikara
    Publication type:
    Article
    36

    Radiotherapy plus androgen deprivation therapy for prostate‐specific antigen persistence in lymph node–positive prostate cancer.

    Published in:
    Cancer Science, 2022, v. 113, n. 7, p. 2386, doi. 10.1111/cas.15383
    By:
    • Shiota, Masaki;
    • Takamatsu, Dai;
    • Kimura, Takahiro;
    • Tashiro, Kojiro;
    • Matsui, Yoshiyuki;
    • Tomida, Ryotaro;
    • Saito, Ryoichi;
    • Tsutsumi, Masakazu;
    • Yokomizo, Akira;
    • Yamamoto, Yoshiyuki;
    • Edamura, Kohei;
    • Miyake, Makito;
    • Morizane, Shuichi;
    • Yoshino, Takayuki;
    • Matsukawa, Akihiro;
    • Narita, Shintaro;
    • Matsumoto, Ryuji;
    • Kasahara, Takashi;
    • Hashimoto, Kohei;
    • Matsumoto, Hiroaki
    Publication type:
    Article
    37

    Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis.

    Published in:
    World Journal of Urology, 2023, v. 41, n. 8, p. 2051, doi. 10.1007/s00345-022-04030-2
    By:
    • Yanagisawa, Takafumi;
    • Kimura, Takahiro;
    • Hata, Kenichi;
    • Narita, Shintaro;
    • Hatakeyama, Shingo;
    • Mori, Keiichiro;
    • Sano, Takayuki;
    • Otsuka, Takashi;
    • Iwamoto, Yuya;
    • Enei, Yuki;
    • Nakazono, Minoru;
    • Sakanaka, Keigo;
    • Iwatani, Kosuke;
    • Matsukawa, Akihiro;
    • Atsuta, Mahito;
    • Nishikawa, Hideomi;
    • Tsuzuki, Shunsuke;
    • Miki, Jun;
    • Habuchi, Tomonori;
    • Ohyama, Chikara
    Publication type:
    Article
    38

    Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study.

    Published in:
    World Journal of Urology, 2023, v. 41, n. 1, p. 67, doi. 10.1007/s00345-022-04237-3
    By:
    • Ozaki, Kai;
    • Hatakeyama, Shingo;
    • Narita, Shintaro;
    • Hata, Kenichi;
    • Yanagisawa, Takafumi;
    • Tanaka, Toshikazu;
    • Togashi, Kyo;
    • Hamaya, Tomoko;
    • Okamoto, Teppei;
    • Yamamoto, Hayato;
    • Yoneyama, Takahiro;
    • Hashimoto, Yasuhiro;
    • Kimura, Takahiro;
    • Habuchi, Tomonori;
    • Ohyama, Chikara
    Publication type:
    Article
    39

    Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy.

    Published in:
    World Journal of Urology, 2022, v. 40, n. 5, p. 1135, doi. 10.1007/s00345-022-03963-y
    By:
    • Narita, Shintaro;
    • Kimura, Takahiro;
    • Hatakeyama, Shingo;
    • Hata, Kenichi;
    • Yanagisawa, Takafumi;
    • Maita, Shinya;
    • Chiba, Shuji;
    • Sato, Hiromi;
    • Kashima, Soki;
    • Koizumi, Atsushi;
    • Yamamoto, Ryohei;
    • Takayama, Koichiro;
    • Okane, Katsumi;
    • Ishida, Toshiya;
    • Horikawa, Yohei;
    • Kumazawa, Teruaki;
    • Shimoda, Jiro;
    • Suzuki, Takehiro;
    • Ohyama, Chikara;
    • Egawa, Shin
    Publication type:
    Article
    40

    Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer.

    Published in:
    World Journal of Urology, 2019, v. 37, n. 11, p. 2365, doi. 10.1007/s00345-019-02664-3
    By:
    • Hamano, Itsuto;
    • Hatakeyama, Shingo;
    • Narita, Shintaro;
    • Takahashi, Masahiro;
    • Sakurai, Toshihiko;
    • Kawamura, Sadafumi;
    • Hoshi, Senji;
    • Ishida, Masanori;
    • Kawaguchi, Toshiaki;
    • Ishidoya, Shigeto;
    • Shimoda, Jiro;
    • Sato, Hiromi;
    • Mitsuzuka, Koji;
    • Tochigi, Tatsuo;
    • Tsuchiya, Norihiko;
    • Arai, Yoichi;
    • Habuchi, Tomonori;
    • Ohyama, Chikara
    Publication type:
    Article
    41

    Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan.

    Published in:
    World Journal of Urology, 2019, v. 37, n. 9, p. 1827, doi. 10.1007/s00345-018-2590-2
    By:
    • Okamoto, Teppei;
    • Hatakeyama, Shingo;
    • Narita, Shintaro;
    • Takahashi, Masahiro;
    • Sakurai, Toshihiko;
    • Kawamura, Sadafumi;
    • Hoshi, Senji;
    • Ishida, Masanori;
    • Kawaguchi, Toshiaki;
    • Ishidoya, Shigeto;
    • Shimoda, Jiro;
    • Sato, Hiromi;
    • Mitsuzuka, Koji;
    • Tochigi, Tatsuo;
    • Tsuchiya, Norihiko;
    • Arai, Yoichi;
    • Habuchi, Tomonori;
    • Ohyama, Chikara
    Publication type:
    Article
    42
    43
    44
    45
    46

    Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.

    Published in:
    International Journal of Cancer, 2008, v. 123, n. 11, p. 2574, doi. 10.1002/ijc.23578
    By:
    • Ma, Zhiyong;
    • Tsuchiya, Norihiko;
    • Yuasa, Takeshi;
    • Inoue, Takamitsu;
    • Kumazawa, Teruaki;
    • Narita, Shintaro;
    • Horikawa, Yohei;
    • Tsuruta, Hiroshi;
    • Obara, Takashi;
    • Saito, Mitsuru;
    • Satoh, Shigeru;
    • Ogawa, Osamu;
    • Habuchi, Tomonori
    Publication type:
    Article
    47
    48

    Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 6, p. 3872, doi. 10.1245/s10434-024-14999-2
    By:
    • Shiota, Masaki;
    • Takamatsu, Dai;
    • Matsui, Yoshiyuki;
    • Yokomizo, Akira;
    • Morizane, Shuichi;
    • Saito, Ryoichi;
    • Miyake, Makito;
    • Tsutsumi, Masakazu;
    • Yamamoto, Yoshiyuki;
    • Tashiro, Kojiro;
    • Tomida, Ryotaro;
    • Narita, Shintaro;
    • Edamura, Kohei;
    • Yamaguchi, Takahiro;
    • Hashimoto, Kohei;
    • Kato, Masashi;
    • Kasahara, Takashi;
    • Yoshino, Takayuki;
    • Akamatsu, Shusuke;
    • Kaneko, Tomoyuki
    Publication type:
    Article
    49

    Impact of Nerve-Sparing Status on Positive Surgical Margin Location and Biochemical Recurrence in Patients with Prostate Cancer Post Radical Prostatectomy.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 9, p. 5341, doi. 10.1245/s10434-021-10281-x
    By:
    • Matsuda, Yoshinori;
    • Narita, Shintaro;
    • Okubo, Teppei;
    • Mitsuzuka, Koji;
    • Hatakeyama, Shingo;
    • Koizumi, Atsushi;
    • Koie, Takuya;
    • Kawamura, Sadafumi;
    • Tochigi, Tatsuo;
    • Ito, Akihiro;
    • Oyama, Chikara;
    • Arai, Yoichi;
    • Habuchi, Tomonori
    Publication type:
    Article
    50